Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Dopamine Dynamics in Obesity
NCT07915986Phase 1Not yet recruiting
- Sponsor
- Yale University
- Start
- Nov 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Yale University. Primary endpoints: Dopamine Release at Week 4, Time to Onset of Dopamine Peaks at Week 4 and 1 more. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07915986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07915986.